Parkinson’s Insights share our latest clinical publication and transitional journey towards Class IIa medical device certification
Charco Neurotech prepares to relaunch CUE1+ following trial findings and medical device certification. Read article
News
In the Press
Discover how we’re making headlines in healthcare.
Parkinson’s UK share our latest clinical publication
Results from a clinical trial of CUE1+, a chest-mounted device, has shown it’s well tolerated by people with Parkinson’s and has the potential to…
Charco Neurotech announces publication of a pilot RCT, with data highlighting that the CUE1+ is safe, well tolerated, with encouraging signals for motor symptom relief in people with Parkinson’s
A double-blind, placebo-controlled study of 50 people with Parkinson’s, published in Parkinson’s Disease, part of the Nature Portfolio, is the first randomised sham-controlled trial of the sternum-worn therapeutic device …
Charco Neurotech Achieves ISO 13485:2016 Certification
We are proud to announce that we have achieved ISO 13485 certification, the internationally recognised quality management system standard for Medical Devices, issued by…
CUE1+ device improves motor and non-motor outcomes in Parkinson’s disease: Findings from a QMUL double-blind, sham-controlled, randomised study
A landmark clinical trial, pre-published in MedRxiv, has found that Charco Neurotech’s non-invasive wearable cueing and vibrotactile stimulation device, CUE1+, delivers improvements for both…
A Letter from our CEO
I am immensely proud of the team at Charco and honoured to be leading our efforts to bring back smiles to people with Parkinson’s.
Preventing and Reducing Falls in People with Parkinson’s
In May, the Parkinson’s lecture series hosted by Charco continued with a talk on the risk of falls presented by Dr Viktoria Azoidou. Viktoria…
The CUE1, created by Charco Neurotech, is being used by former BBC technology correspondent Rory Cellan-Jones
The CUE1, created by Charco Neurotech, is being used by former BBC technology correspondent Rory Cellan-Jones. Read article
Imperial startup joins forces with QMUL on medtech to help Parkinson’s sufferers
Charco Neurotech, founded at Imperial, will work with Queen Mary University of London, to test its device for alleviating the symptoms of Parkinson’s. Read…